Updating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer : an update from the PIONEER Consortium

Beyer, KatharinaMoris, LisaLardas, MichaelOmar, Muhammad ImranHealey, JemmaTripatheed, SheelaGandaglia, GiorgioVenderbos, Lionne DFVradi, Elenivan den Broeck, ThomasWillemse, Peter-Paul M.Antunes-Lopes, TiagoPacheco-Figueiredo, LuísMonagas Arteaga, SerenellaEsperto, FrancescoFlaherty, StephenDevecseri, ZsuzsannaLam, ThomasWilliamson, Paula R.Heer, RakeshSmith, Emma JaneAsiimwe, AlexHuber, JohannesRoobol, Monique JZong, JihongMason, Malcolm D.Cornford, PhilipMottet, NicolasMacLennan, SaraN'Dow, JamesBrigantii, AlbertoMacLennan, StevenVan Hemelrijck, MiekePIONEER Consortium2022-07-152022-07-152022-05Beyer, K, Moris, L, Lardas, M, Omar, M I, Healey, J, Tripatheed, S, Gandaglia, G, Venderbos, L DF, Vradi, E, van den Broeck, T, Willemse, P-P M, Antunes-Lopes, T, Pacheco-Figueiredo, L, Monagas Arteaga, S, Esperto, F, Flaherty, S, Devecseri, Z, Lam, T, Williamson, P R, Heer, R, Smith, E J, Asiimwe, A, Huber, J, Roobol, M J, Zong, J, Mason, M D, Cornford, P, Mottet, N, MacLennan, S, N'Dow, J, Brigantii, A, MacLennan, S, Van Hemelrijck, M & PIONEER Consortium 2022, 'Updating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer : an update from the PIONEER Consortium ', European Urology, vol. 81, no. 5, pp. 503-514. https://doi.org/10.1016/j.eururo.2022.01.0420302-2838ORCID: /0000-0003-1405-6964/work/116105487ORCID: /0000-0002-2691-8421/work/116747626ORCID: /0000-0002-1597-3126/work/116747699ORCID: /0000-0001-5340-0081/work/162725293https://hdl.handle.net/2164/18876Acknowledgements: We are thankful to all the patients and health care professionals who took part in our interview studies and to the patient representatives and advocates who provided insight during our various consensus meetings. We are grateful to Dr. Susie Dodd for her advice in applying the 38-item outcome taxonomy which she and her COMET colleagues developed, and we accept responsibility for any (mis)application. PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint under- taking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.121095087engSDG 3 - Good Health and Well-beingProstate CancerPatient pathwayComparative effectiveness researchCore outcome setsStandardised outcome setsOutcomesRandomized controlled trialsSystematic reviewsBig DataReal world DataR MedicineUrologyEuropean Commission777492Supplementary DataRUpdating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer : an update from the PIONEER ConsortiumJournal article10.1016/j.eururo.2022.01.042http://www.scopus.com/inward/record.url?scp=85124810302&partnerID=8YFLogxK815